SLC24A5
geneOn this page
Also known as JSXOCA6NCKX5
Summary
SLC24A5 (solute carrier family 24 member 5, HGNC:20611) is a protein-coding gene on chromosome 15q21.1, encoding Sodium/potassium/calcium exchanger 5 (Q71RS6). Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) to the melanosome in exchange for 4 cytoplasmic Na(+).
This gene is a member of the potassium-dependent sodium/calcium exchanger family and encodes an intracellular membrane protein with 2 large hydrophilic loops and 2 sets of multiple transmembrane-spanning segments. Sequence variation in this gene has been associated with differences in skin pigmentation.
Source: NCBI Gene 283652 — RefSeq curated summary.
At a glance
- Gene–disease (curated): oculocutaneous albinism type 6 (Definitive, GenCC)
- GWAS associations: 21
- Clinical variants (ClinVar): 126 total — 12 pathogenic, 6 likely-pathogenic
- Phenotypes (HPO): 12
- MANE Select transcript:
NM_205850
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20611 |
| Approved symbol | SLC24A5 |
| Name | solute carrier family 24 member 5 |
| Location | 15q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | JSX, OCA6, NCKX5 |
| Ensembl gene | ENSG00000188467 |
| Ensembl biotype | protein_coding |
| OMIM | 609802 |
| Entrez | 283652 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000341459, ENST00000449382, ENST00000463289, ENST00000482911
RefSeq mRNA: 1 — MANE Select: NM_205850
NM_205850
CCDS: CCDS10128
Canonical transcript exons
ENST00000341459 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001364100 | 48121857 | 48122036 |
| ENSE00001364865 | 48138969 | 48139175 |
| ENSE00001382203 | 48120990 | 48121165 |
| ENSE00001384487 | 48141113 | 48141214 |
| ENSE00001385395 | 48136683 | 48136963 |
| ENSE00001919044 | 48142029 | 48142672 |
| ENSE00003489229 | 48134258 | 48134341 |
| ENSE00003647742 | 48134884 | 48134984 |
| ENSE00003667994 | 48134435 | 48134538 |
Expression profiles
Bgee: expression breadth broad, 59 present calls, max score 77.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 3.4565 / max 738.4617, expressed in 114 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 146537 | 1.9951 | 102 |
| 146538 | 1.4614 | 72 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.11 | gold quality |
| quadriceps femoris | UBERON:0001377 | 61.89 | gold quality |
| skin of abdomen | UBERON:0001416 | 60.58 | gold quality |
| thymus | UBERON:0002370 | 60.50 | silver quality |
| zone of skin | UBERON:0000014 | 60.25 | gold quality |
| vastus lateralis | UBERON:0001379 | 60.14 | gold quality |
| cerebellar vermis | UBERON:0004720 | 59.81 | gold quality |
| skin of leg | UBERON:0001511 | 59.34 | gold quality |
| trachea | UBERON:0003126 | 59.07 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 59.03 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 58.67 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 58.19 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 57.91 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 55.97 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| substantia nigra | UBERON:0002038 | 47.81 | gold quality |
| endometrium epithelium | UBERON:0004811 | 46.85 | gold quality |
| bone marrow cell | CL:0002092 | 46.81 | gold quality |
| cerebellum | UBERON:0002037 | 46.58 | silver quality |
| cerebellar cortex | UBERON:0002129 | 46.32 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 45.92 | silver quality |
| sural nerve | UBERON:0015488 | 45.57 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 43.96 | silver quality |
| duodenum | UBERON:0002114 | 43.92 | gold quality |
| testis | UBERON:0000473 | 43.79 | gold quality |
| right testis | UBERON:0004534 | 43.36 | gold quality |
| bone marrow | UBERON:0002371 | 42.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.11 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 22)
- the variant allele is associated with a substantial reduction in regional heterozygosity, and correlates with lighter skin pigmentation in admixed populations, suggesting a key role for the SLC24A5 gene in human pigmentation (PMID:16357253)
- The p.L374F allele in SLC45A2 is a more specific ancestry informative marker than the p.A111T allele in SLC24A5, as it clearly distinguishes Sri Lankans from Europeans. (PMID:16847698)
- The NCKX5 protein, encoded by the SLC24A5 gene, is localized to the trans-Golgi network where it may influence melanosomal assembly. The SLC24A5 allele encoding threonine-111 confers reduced NCKX5 activity. (PMID:18166528)
- non-synonymous single nucleotide polymorphism in SLC24A5 alters a residue that is important for NCKX5 and NCKX2 activity (PMID:18166528)
- Greek subjects showed a prevalence of the Thr(111) allele variant of the SLC24A5 gene, even among subjects with darker skin pigmentation or phototype. (PMID:18637132)
- higher tyrosinase protein abundance was not observed for any NCKX5-111 allele variation (PMID:18650849)
- NCKX5, a natural regulator of human skin colour variation, regulates the expression of key pigment genes MC1R and alpha-MSH and alters cholesterol homeostasis in normal human melanocytes. (PMID:23224873)
- SLC24A5 is a previously unreported nonsyndromic oculocutaneous albinism candidate gene. (PMID:23364476)
- We observed a heterogeneous phenotype among seven oculocutaneous albinism patients with SLC24A5 mutations. (PMID:23985994)
- All chromosomes carrying the A111T allele of SLC24A5 gene share a single 78-kb haplotype indicating that all instances of this mutation in human populations share a common origin. (PMID:24048645)
- Sequencing 11.74 kb of SLC24A5 in 95 individuals worldwide reveals that the rs1426654-A alleles in South Asian and West Eurasian populations are monophyletic and occur on the background of a common haplotype that is characterized by low genetic diversity (PMID:24244186)
- the SLC24A5 gene locus known to be associated with skin pigmentation was in the top selection signals in the Wolaita, and the alleles of single-nucleotide polymorphisms rs1426654 and rs1834640 (SLC24A5) associated with light skin pigmentation (PMID:25370040)
- Polymorphisms of SLC24A5 were found to be associated with skin, hair, and eye color in a phenotypically diverse Brazilian population, considered useful in forensic science for crime investigation and facial reconstruction in unknown bodies. (PMID:25801600)
- a novel homozygous mutation in SLC24A5 in two patients from French Guiana strengthens the importance of screening this gene in oculocutaneous albinism patients. (PMID:26491832)
- Letter/Case Report: OCA6 mutation in 6 year old boy with oculocutaneous albinism. (PMID:26686029)
- mutations in SLC24A4 and SLC24A5 are responsible for the phenotypic defects observed in human amylogenesis imperfecta and non-syndromic oculocutaneous albinism patients. (PMID:27129268)
- both polymorphisms (rs1426654 and rs2470102) play an important role in the skin pigmentation diversity of South Asians (PMID:27866970)
- NCKX5 is not a plasma membrane resident and is exclusively located in the trans Golgi network. (PMID:29981211)
- The derived causal allele in SLC24A5, p.Ala111Thr, significantly lightens basal skin pigmentation in the KhoeSan and explains 8 to 15% of phenotypic variance in these populations. The frequency of this allele (33 to 53%) is far greater than expected from gene flow. We show that the allele was introduced into the KhoeSan only 2,000 y ago via a back-to-Africa migration and then experienced a selective sweep. (PMID:30530665)
- This study identifies two novel SLC24A5 frame-shift variants in two unrelated Chinese oculocutaneous albinism type 6 patients. (PMID:31486119)
- Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA6. (PMID:32274888)
- Native American genetic ancestry and pigmentation allele contributions to skin color in a Caribbean population. (PMID:37294081)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc24a5 | ENSDARG00000024771 |
| mus_musculus | Slc24a5 | ENSMUSG00000035183 |
| rattus_norvegicus | Slc24a5 | ENSRNOG00000005158 |
| drosophila_melanogaster | CG1090 | FBGN0037238 |
Paralogs (4): SLC24A1 (ENSG00000074621), SLC24A4 (ENSG00000140090), SLC24A2 (ENSG00000155886), SLC24A3 (ENSG00000185052)
Protein
Protein identifiers
Sodium/potassium/calcium exchanger 5 — Q71RS6 (reviewed: Q71RS6)
Alternative names: Na(+)/K(+)/Ca(2+)-exchange protein 5, Solute carrier family 24 member 5
All UniProt accessions (2): Q71RS6, H0YLZ0
UniProt curated annotations — full annotation on UniProt →
Function. Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) to the melanosome in exchange for 4 cytoplasmic Na(+). Involved in pigmentation, possibly by participating in ion transport in melanosomes. Predominant sodium-calcium exchanger in melanocytes.
Subcellular location. Golgi apparatus. trans-Golgi network membrane. Melanosome.
Disease relevance. Albinism, oculocutaneous, 6 (OCA6) [MIM:113750] A disorder characterized by a reduction or complete loss of melanin in the skin, hair and eyes. Patients show reduced or lacking pigmentation often accompanied by eye symptoms such as photophobia, strabismus, moderate to severe visual impairment, and nystagmus. The disease is caused by variants affecting the gene represented in this entry.
Polymorphism. Genetic variants in SLC24A5 define the skin/hair/eye pigmentation variation locus 4 (SHEP4) [MIM:113750]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair. The Ala-111 allele predominates (93 to 100%) in African and East Asian populations. In contrast, the Thr-111 allele is nearly fixed (98.7 to 100%) in European populations, is associated with a substantial reduction in regional heterozygosity, and correlates with lighter skin pigmentation in admixed populations.
Similarity. Belongs to the Ca(2+):cation antiporter (CaCA) (TC 2.A.19) family. SLC24A subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q71RS6-1 | 1 | yes |
| Q71RS6-2 | 2 |
RefSeq proteins (1): NP_995322* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004481 | K/Na/Ca-exchanger | Family |
| IPR004837 | NaCa_Exmemb | Domain |
| IPR044880 | NCX_ion-bd_dom_sf | Homologous_superfamily |
Pfam: PF01699
Catalyzed reactions (Rhea), 1 shown:
- Ca(2+)(out) + K(+)(out) + 4 Na(+)(in) = Ca(2+)(in) + K(+)(in) + 4 Na(+)(out) (RHEA:69967)
UniProt features (27 total): topological domain 12, transmembrane region 11, signal peptide 1, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q71RS6-F1 | 76.63 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-425561 | Sodium/Calcium exchangers |
| R-HSA-5619036 | Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) |
| R-HSA-1643685 | Disease |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425393 | |
| R-HSA-425407 | SLC-mediated transmembrane transport |
| R-HSA-5619102 | SLC transporter disorders |
| R-HSA-5619115 | Disorders of transmembrane transporters |
MSigDB gene sets: 107 (showing top):
GOBP_POTASSIUM_ION_TRANSPORT, GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOCC_TRANS_GOLGI_NETWORK, GOBP_CALCIUM_ION_IMPORT, WTGAAAT_UNKNOWN, GOBP_PIGMENT_METABOLIC_PROCESS, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GATA1_02, GOBP_PIGMENT_BIOSYNTHETIC_PROCESS, GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT
GO Biological Process (13): monoatomic ion transport (GO:0006811), intracellular calcium ion homeostasis (GO:0006874), monoatomic ion transmembrane transport (GO:0034220), melanin biosynthetic process (GO:0042438), negative regulation of melanin biosynthetic process (GO:0048022), calcium ion import (GO:0070509), calcium ion transmembrane transport (GO:0070588), potassium ion transport (GO:0006813), sodium ion transport (GO:0006814), calcium ion transport (GO:0006816), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085), potassium ion transmembrane transport (GO:0071805)
GO Molecular Function (7): calcium channel activity (GO:0005262), calcium, potassium:sodium antiporter activity (GO:0008273), symporter activity (GO:0015293), calcium:sodium antiporter activity (GO:0005432), protein binding (GO:0005515), calcium ion transmembrane transporter activity (GO:0015085), antiporter activity (GO:0015297)
GO Cellular Component (5): trans-Golgi network (GO:0005802), trans-Golgi network membrane (GO:0032588), melanosome (GO:0042470), Golgi apparatus (GO:0005794), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Metal ion SLC transporters | 1 |
| SLC transporter disorders | 1 |
| Transport of small molecules | 1 |
| Disorders of transmembrane transporters | 1 |
| Disease | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| monoatomic cation transmembrane transport | 3 |
| metal ion transport | 3 |
| transport | 2 |
| calcium ion transport | 2 |
| secondary active transmembrane transporter activity | 2 |
| intracellular monoatomic cation homeostasis | 1 |
| calcium ion homeostasis | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| melanin metabolic process | 1 |
| secondary metabolite biosynthetic process | 1 |
| pigment biosynthetic process | 1 |
| phenol-containing compound biosynthetic process | 1 |
| melanin biosynthetic process | 1 |
| regulation of melanin biosynthetic process | 1 |
| negative regulation of secondary metabolite biosynthetic process | 1 |
| sodium ion transport | 1 |
| cellular process | 1 |
| potassium ion transport | 1 |
| monoatomic cation channel activity | 1 |
| calcium ion transmembrane transporter activity | 1 |
| calcium:sodium antiporter activity | 1 |
| solute:potassium antiporter activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| calcium:monoatomic cation antiporter activity | 1 |
| binding | 1 |
| metal ion transmembrane transporter activity | 1 |
| calcium ion transmembrane transport | 1 |
| Golgi apparatus subcompartment | 1 |
| trans-Golgi network | 1 |
| organelle membrane | 1 |
| pigment granule | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1047 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC24A5 | SLC45A2 | Q9UMX9 | 983 |
| SLC24A5 | OCA2 | Q04671 | 946 |
| SLC24A5 | EDAR | Q9UNE0 | 903 |
| SLC24A5 | TPCN2 | Q8NHX9 | 903 |
| SLC24A5 | TYRP1 | P17643 | 881 |
| SLC24A5 | TYR | P14679 | 870 |
| SLC24A5 | MC1R | Q01726 | 859 |
| SLC24A5 | EDA2R | Q9HAV5 | 828 |
| SLC24A5 | LRMDA | Q9H2I8 | 773 |
| SLC24A5 | ASIP | P42127 | 749 |
| SLC24A5 | GPR143 | P51810 | 667 |
| SLC24A5 | IRF4 | Q15306 | 623 |
| SLC24A5 | DCT | P40126 | 619 |
| SLC24A5 | CTXN2 | P0C2S0 | 616 |
| SLC24A5 | PMEL | P40967 | 610 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX2 | SLC24A5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC24A5 | TMEM186 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC24A5 | SYVN1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC24A5 | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| SLC24A5 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (39): ABCB10 (Affinity Capture-MS), TMEM186 (Affinity Capture-MS), SYVN1 (Affinity Capture-MS), SLC24A5 (Two-hybrid), ABCB10 (Affinity Capture-MS), TMEM186 (Affinity Capture-MS), ABCB10 (Affinity Capture-MS), B4GAT1 (Affinity Capture-MS), BNIP1 (Affinity Capture-MS), CCNT1 (Affinity Capture-MS), CEP170 (Affinity Capture-MS), CSDE1 (Affinity Capture-MS), EIF5B (Affinity Capture-MS), ENAH (Affinity Capture-MS), ERLEC1 (Affinity Capture-MS)
ESM2 similar proteins: A0AV02, A2AWR3, A2VCW5, A4QN56, A6QP84, B2RXV4, D4A7H1, F7B113, G8XYX6, O08705, O70324, P09131, P19634, P21129, P23791, P26431, P26434, P26435, P36021, P48761, P48762, P97751, Q0V8N6, Q14973, Q28036, Q3KNW5, Q3UEZ8, Q4JLT5, Q5PT54, Q5PT56, Q5R9A7, Q61165, Q70EX6, Q71RS6, Q7Z3F1, Q8BFW9, Q8BLV3, Q8BUE1, Q8BZ00, Q8C261
Diamond homologs: F1NXU8, O04034, O60721, Q49SH1, Q6AXS0, Q6J4K2, Q71RS6, Q925Q3, Q9FKP1, Q9FKP2, O16242, P87122, Q8CGQ8, Q8NFF2, Q99PD7, Q9EPQ0, Q9HC58, Q9U6A0, Q9VN12, P34315, P34322, Q8C261, Q91WD8, Q9IAL8, B8K1V7, O22252, O46383, O54701, P23685, P32418, P45394, P48765, P48766, P48767, P48768, P70414, Q01728, Q0ZAI3, Q28139, Q2R041
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SLC24A5 | “down-regulates quantity” | calcium(2+) | relocalization |
| SLC24A5 | “down-regulates quantity” | potassium(1+) | relocalization |
| SLC24A5 | “up-regulates quantity” | sodium(1+) | relocalization |
Disease & clinical
Clinical variants and AI predictions
ClinVar
126 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 12 |
| Likely pathogenic | 6 |
| Uncertain significance | 55 |
| Likely benign | 46 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (18)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1284554 | NM_205850.3(SLC24A5):c.184C>T (p.Gln62Ter) | Pathogenic |
| 1408941 | NM_205850.3(SLC24A5):c.20_29del (p.Gln7fs) | Pathogenic |
| 2048016 | NM_205850.3(SLC24A5):c.279del (p.Ser94fs) | Pathogenic |
| 2115752 | NM_205850.3(SLC24A5):c.133del (p.Gln45fs) | Pathogenic |
| 2116280 | NM_205850.3(SLC24A5):c.96del (p.Gln34fs) | Pathogenic |
| 2133309 | NM_205850.3(SLC24A5):c.26G>A (p.Trp9Ter) | Pathogenic |
| 2137667 | NM_205850.3(SLC24A5):c.216T>G (p.Tyr72Ter) | Pathogenic |
| 2137668 | NM_205850.3(SLC24A5):c.344C>A (p.Ala115Glu) | Pathogenic |
| 3342242 | GRCh37/hg19 15q21.1(chr15:48413242-48414233)x0 | Pathogenic |
| 3649840 | NM_205850.3(SLC24A5):c.430G>T (p.Gly144Ter) | Pathogenic |
| 4715838 | NM_205850.3(SLC24A5):c.83C>G (p.Ser28Ter) | Pathogenic |
| 985686 | NM_205850.3(SLC24A5):c.989G>A (p.Trp330Ter) | Pathogenic |
| 1515737 | NM_205850.3(SLC24A5):c.591-1G>A | Likely pathogenic |
| 2003903 | NM_205850.3(SLC24A5):c.302-1G>C | Likely pathogenic |
| 2013425 | NM_205850.3(SLC24A5):c.121+1G>A | Likely pathogenic |
| 2069572 | NM_205850.3(SLC24A5):c.489+2T>C | Likely pathogenic |
| 3027497 | NM_205850.3(SLC24A5):c.301+1G>T | Likely pathogenic |
| 4073705 | NM_205850.3(SLC24A5):c.328G>C (p.Gly110Arg) | Likely pathogenic |
SpliceAI
967 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:48141107:TTACA:T | acceptor_loss | 0.9900 |
| 15:48141108:TACAG:T | acceptor_loss | 0.9900 |
| 15:48141110:CAGG:C | acceptor_loss | 0.9900 |
| 15:48141111:A:AG | acceptor_gain | 0.9900 |
| 15:48141111:AG:A | acceptor_gain | 0.9900 |
| 15:48141111:AGG:A | acceptor_gain | 0.9900 |
| 15:48141111:AGGGG:A | acceptor_loss | 0.9900 |
| 15:48141112:G:GG | acceptor_gain | 0.9900 |
| 15:48141112:GG:G | acceptor_gain | 0.9900 |
| 15:48141112:GGG:G | acceptor_gain | 0.9900 |
| 15:48141210:AAAAG:A | donor_loss | 0.9900 |
| 15:48141211:AAAG:A | donor_loss | 0.9900 |
| 15:48141212:AAGGT:A | donor_loss | 0.9900 |
| 15:48141213:AG:A | donor_loss | 0.9900 |
| 15:48141214:GGTA:G | donor_loss | 0.9900 |
| 15:48141215:G:C | donor_loss | 0.9900 |
| 15:48141216:T:G | donor_loss | 0.9900 |
| 15:48121161:CACAG:C | donor_loss | 0.9800 |
| 15:48121162:ACAGG:A | donor_loss | 0.9800 |
| 15:48121164:AGGTA:A | donor_loss | 0.9800 |
| 15:48121166:G:GC | donor_loss | 0.9800 |
| 15:48121167:T:G | donor_loss | 0.9800 |
| 15:48134256:A:AG | acceptor_gain | 0.9800 |
| 15:48134257:G:GG | acceptor_gain | 0.9800 |
| 15:48141098:ATCT:A | acceptor_loss | 0.9800 |
| 15:48141106:ATTAC:A | acceptor_loss | 0.9800 |
| 15:48122037:G:GG | donor_gain | 0.9700 |
| 15:48134251:T:G | acceptor_gain | 0.9700 |
| 15:48134434:GGT:G | acceptor_gain | 0.9700 |
| 15:48136930:A:G | donor_gain | 0.9700 |
AlphaMissense
3244 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:48134938:A:C | S182R | 0.987 |
| 15:48134940:T:A | S182R | 0.987 |
| 15:48134940:T:G | S182R | 0.987 |
| 15:48141172:A:C | S380R | 0.983 |
| 15:48141174:C:A | S380R | 0.983 |
| 15:48141174:C:G | S380R | 0.983 |
| 15:48141193:A:C | S387R | 0.982 |
| 15:48141195:T:A | S387R | 0.982 |
| 15:48141195:T:G | S387R | 0.982 |
| 15:48139127:T:A | W344R | 0.974 |
| 15:48139127:T:C | W344R | 0.974 |
| 15:48121896:T:G | F54C | 0.973 |
| 15:48141149:T:C | L372P | 0.970 |
| 15:48121895:T:C | F54L | 0.969 |
| 15:48121897:T:A | F54L | 0.969 |
| 15:48121897:T:G | F54L | 0.969 |
| 15:48134467:A:C | S140R | 0.967 |
| 15:48134469:C:A | S140R | 0.967 |
| 15:48134469:C:G | S140R | 0.967 |
| 15:48142100:T:A | W418R | 0.967 |
| 15:48142100:T:C | W418R | 0.967 |
| 15:48134513:C:A | A155D | 0.966 |
| 15:48141161:C:A | A376E | 0.966 |
| 15:48139157:T:A | W354R | 0.964 |
| 15:48139157:T:C | W354R | 0.964 |
| 15:48142085:T:C | C413R | 0.959 |
| 15:48139035:C:G | P313R | 0.956 |
| 15:48134916:A:C | R174S | 0.953 |
| 15:48134916:A:T | R174S | 0.953 |
| 15:48141160:G:C | A376P | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000127470 (15:48129382 A>G), RS1000148716 (15:48129963 C>T), RS1000260087 (15:48133935 T>C), RS1000291151 (15:48133524 G>A), RS1000308736 (15:48134750 C>A,G,T), RS1000348687 (15:48141766 A>C), RS1000360818 (15:48126063 G>A,C,T), RS1000404281 (15:48141484 G>A), RS1000770339 (15:48141539 G>A,C,T), RS1000805844 (15:48121503 G>A), RS1000814902 (15:48126432 T>C), RS1000837031 (15:48121145 A>G), RS1000906189 (15:48136441 G>A,C,T), RS1001133418 (15:48129315 T>C), RS1001183229 (15:48125453 C>T)
Disease associations
OMIM: gene MIM:609802 | disease phenotypes: MIM:113750
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| oculocutaneous albinism type 6 | Definitive | Autosomal recessive |
Mondo (1): oculocutaneous albinism type 6 (MONDO:0018264)
Orphanet (1): Oculocutaneous albinism type 6 (Orphanet:370097)
HPO phenotypes
12 total (12 of 12 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000505 | Visual impairment |
| HP:0000613 | Photophobia |
| HP:0000639 | Nystagmus |
| HP:0001098 | Abnormal fundus morphology |
| HP:0002286 | Fair hair |
| HP:0007513 | Generalized hypopigmentation |
| HP:0007663 | Reduced visual acuity |
| HP:0007750 | Hypoplasia of the fovea |
| HP:0008034 | Abnormal iris pigmentation |
| HP:0008059 | Aplasia/Hypoplasia of the macula |
| HP:0030613 | Abnormal foveal morphology on macular OCT |
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000114_3 | Skin pigmentation | 1.000000e-50 |
| GCST002571_1 | Body mass index | 4.000000e-07 |
| GCST002571_4 | Body mass index | 8.000000e-07 |
| GCST003479_8 | Hair color | 1.000000e-18 |
| GCST004219_4 | Skin pigmentation | 3.000000e-14 |
| GCST005188_1 | Skin pigmentation | 4.000000e-12 |
| GCST005188_3 | Skin pigmentation | 1.000000e-08 |
| GCST007324_119 | Adventurousness | 2.000000e-08 |
| GCST007451_11 | Skin, hair and eye pigmentation (multivariate analysis) | 4.000000e-150 |
| GCST007452_9 | Skin pigmentation | 2.000000e-130 |
| GCST007453_7 | Eye color | 1.000000e-26 |
| GCST007454_7 | Hair color | 1.000000e-18 |
| GCST007455_5 | Eye color (brightness) | 8.000000e-50 |
| GCST007457_7 | Eye color (saturation) | 6.000000e-45 |
| GCST007740_28 | Iris color (a* coordinate) | 2.000000e-06 |
| GCST007741_10 | Iris color (b* coordinate) | 8.000000e-09 |
| GCST008518_5 | Skin pigmentation | 3.000000e-07 |
| GCST008519_7 | Skin pigmentation | 6.000000e-39 |
| GCST009391_676 | Metabolite levels | 2.000000e-06 |
| GCST010302_13 | Cutaneous melanoma or hair colour | 1.000000e-09 |
| GCST011355_3 | Skin reflectance (Melanin index) | 4.000000e-30 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0008579 | risk-taking behaviour |
| EFO:0009764 | eye colour measurement |
| EFO:0010506 | kynurenic acid measurement |
| EFO:0003924 | hair color |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC24 family of sodium/potassium/calcium exchangers
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Polychlorinated Biphenyls | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4ES | 1321N1-SLC24A5-KO-c4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: oculocutaneous albinism type 6
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous melanoma, oculocutaneous albinism type 6